SymptoLab
PrivateCompany Overview
SymptoLab is a digital health company that provides an AI-powered clinical decision-support platform to help physicians and patients manage complex, hormone-driven conditions.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Precision Medicine, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymptoLab Comparables
Compare SymptoLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dama Health | 78% | |
| FertilAI | 77% | |
| Syrona Health | 71% | |
SymptoLab Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
Grew 200% QoQ, from 2 to 6 employees.
SymptoLab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SymptoLab's valuation, stock price, and market status.